Cite
HARVARD Citation
Atreya, R. et al. (n.d.). P548 Efficacy outcomes of placebo maintenance treatment in patients with moderate to severe Crohn's disease who responded to placebo induction therapy: Post-hoc analysis of the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Risankizumab Studies. Journal of Crohn's and colitis. pp. i675-i677. [Online].